Biotech

All Articles

Biogen, UCB document phase 3 lupus win after stopping working earlier test

.Biogen and also UCB's bank on improving right into phase 3 on the back of an unsuccessful research ...

Aptadir wishes brand-new RNA preventions can reverse complicated cancers

.Italian biotech Aptadir Rehabs has actually introduced along with the promise that its pipeline of ...

Wave surfs DMD success to regulators' doors, delivering stock up

.Wave Life Sciences has met its own target in a Duchenne muscle dystrophy (DMD) study, positioning i...

Sanofi plucks brand new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is returning to the pharma layer, taking ...

Achilles drops tissue therapy program, bandages for unemployments after missing out on 'commercial stability' targets

.Achilles Therapies has wrecked its own method. The British biotech is actually knocking off on its ...

Aligos declares phase 2 MASH win, reducing liver fat approximately 46%

.Aligos Therapeutics is heralding a midstage win in metabolic-dysfunction linked steatohepatitis (MA...

Basilea credit ratings $268M BARDA financing for antifungals, anti-biotics

.Basilea Pharmaceutica's work establishing brand new antifungals has actually received a considerabl...

Capricor markets Europe rights to late-stage DMD therapy for $35M

.Having actually scooped up the U.S. civil liberties to Capricor Rehabs' late-stage Duchenne muscula...

FDA junks adcomm for Applied's rare disease medication

.After pushing the decision meeting for Applied Therapies' metabolic problem medicine govorestat, th...

Novo inks $600M NanoVation bargain to study genetic drugs ex-liver

.Novo Nordisk is actually proceeding its own push into hereditary medicines, consenting to compensat...